Cargando…
A Case of Hyperimmunoglobulinemia D Syndrome Successfully Treated with Canakinumab
Hyperimmunoglobulinemia D syndrome is a rare autosomal recessive autoinflammatory disorder caused by mutations in the mevalonate kinase gene (MVK). In a proportion of patients, however, no MVK mutations are detected. Although various standard anti-inflammatory drugs have been tried, until now there...
Autores principales: | Tsitsami, Elena, Papadopoulou, Charis, Speletas, Matthaios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652103/ https://www.ncbi.nlm.nih.gov/pubmed/23691418 http://dx.doi.org/10.1155/2013/795027 |
Ejemplares similares
-
Histopathologic features in a case of hyperimmunoglobulinemia D syndrome
por: Pace, Sarah, et al.
Publicado: (2015) -
Neonatal Hepatitis as First Manifestation of Hyperimmunoglobulinemia D Syndrome
por: von Linstow, Marie-Louise, et al.
Publicado: (2014) -
A case of Schnitzler’s syndrome without monoclonal gammopathy successfully treated with canakinumab
por: Fujita, Yuya, et al.
Publicado: (2021) -
Indications and efficacy of canakinumab in Familial Mediterranean Fever: report of three cases
por: Tsinti, Maria, et al.
Publicado: (2014) -
Etiology and management of hyperimmunoglobulinemia E syndrome
por: Gonzalez-Granado, L I
Publicado: (2010)